DiaSorin S.p.A. is an Italian biotechnology company, established in 2000 and headquartered in Saluggia, that develops and markets diagnostic reagent kits for immunodiagnostics and molecular diagnostics used in in vitro testing. Its tests cover infectious disease detection, endocrinology, oncology, autoimmunity and cardiac markers. Since acquiring Luminex Corporation in 2021, the company has also expanded into life sciences. DiaSorin runs production facilities in Europe and North America and is listed on the Italian Stock Exchange as a member of the FTSE MIB index. This description is adapted from Wikipedia contributors under CC BY-SA 4.0; changes were made. https://creativecommons.org/licenses/by-sa/4.0/
Facts
Company Type Founded Year Connections
Operates In
Source Wikidata: DiaSorin
Sources
1. DiaSorin (Wikipedia)
Infobox company, type field
type = [[Public company|Public]]
Infobox company, founded field
founded = {{Start date and age|2000}}
View the SourceWikidata: DiaSorin
WikidataOperates In: Biotechnology Industry, Wikidata statement: industry (P452)Quote, Operates In: Biotechnology Industry, Wikidata statement: industry (P452)
industry (P452) target Q7108, matched to the live industry entity by qid (enwiki-sitelink resolved)
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.